Viruses as Therapeutic Agents for Cancer, Volume 171 in the Advances in Cancer Research series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Coxsackievirus virotherapy, Oncolytic reovirus, Cancer immunotherapy with oncolytic myxoma virus, Zika Virus as an Oncolytic Therapy, Nonreplicative adenoviral vectors for cancer, VSV Oncolytic Virotherapy, AAV vectors for cancer gene therapy, Adenovirus cancer vaccines, Advancing Clinical Translation of Oncolytic Adenoviruses, and Immunotherapuetic Cancer Terminator Viruses.
1. Cover image - p. c 2. Title page - p. iii 3. Copyright - p. iv 4. Contents - p. v 5. Contributors - p. ix 6. Preface - p. xiii 7. 1. Oncolytic viruses in cutaneous oncology: Mechanisms, clinical applications, and future directions - p. 1 8. 2. Operation oncolysis: Reoviruses in the theater of cancer war - p. 23 9. 3. Cancer immunotherapy with oncolytic myxoma virus - p. 91 10. 4. Zika virus as an oncolytic therapy - p. 129 11. 5. Non-replicating adenoviral vectors for cancer gene therapy - p. 143 12. 6. Vesicular stomatitis virus (VSV) as an oncolytic therapeutic agent for cancer - p. 187 13. 7. AAV vectors for cancer gene therapy - p. 219 14. 8. Advancing clinical translation of oncolytic adenoviruses - p. 267 15. 9. Cancer terminator viruses: Unique conditionally replication competent oncolytic viruses producing therapeutic anti-cancer immunomodulating agents - p. 321
Viruses as Therapeutic Agents for Cancer, Volume 171 in the Advances in Cancer Research series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Coxsackievirus virotherapy, Oncolytic reovirus, Cancer immunotherapy with oncolytic myxoma virus, Zika Virus as an Oncolytic Therapy, Nonreplicative adenoviral vectors for cancer, VSV Oncolytic Virotherapy, AAV vectors for cancer gene therapy, Adenovirus cancer vaccines, Advancing Clinical Translation of Oncolytic Adenoviruses, and Immunotherapuetic Cancer Terminator Viruses.
1. Cover image - p. c 2. Title page - p. iii 3. Copyright - p. iv 4. Contents - p. v 5. Contributors - p. ix 6. Preface - p. xiii 7. 1. Oncolytic viruses in cutaneous oncology: Mechanisms, clinical applications, and future directions - p. 1 8. 2. Operation oncolysis: Reoviruses in the theater of cancer war - p. 23 9. 3. Cancer immunotherapy with oncolytic myxoma virus - p. 91 10. 4. Zika virus as an oncolytic therapy - p. 129 11. 5. Non-replicating adenoviral vectors for cancer gene therapy - p. 143 12. 6. Vesicular stomatitis virus (VSV) as an oncolytic therapeutic agent for cancer - p. 187 13. 7. AAV vectors for cancer gene therapy - p. 219 14. 8. Advancing clinical translation of oncolytic adenoviruses - p. 267 15. 9. Cancer terminator viruses: Unique conditionally replication competent oncolytic viruses producing therapeutic anti-cancer immunomodulating agents - p. 321
